Literature DB >> 13983001

Melioidosis--a military medical problem?

H L RUBIN, A D ALEXANDER, R H YAGER.   

Abstract

Entities:  

Keywords:  MELIOIDOSIS; MILITARY PERSONNEL

Mesh：

Year:  1963        PMID： 13983001

Source DB:  PubMed          Journal:  Mil Med        ISSN： 0026-4075            Impact factor:   1.437


× No keyword cloud information.
  7 in total

1.  Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis.

Authors:  M Sookpranee; P Boonma; W Susaengrat; K Bhuripanyo; S Punyagupta
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Pulmonary melioidosis in a patient with diabetes mellitus.

Authors:  I Chofnas
Journal:  Thorax       Date:  1972-03       Impact factor: 9.139

3.  Melioidosis: forgotten but not gone.

Authors:  J P Sanford
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

Review 4.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  A Quadruplex Real-Time PCR Assay for the Rapid Detection and Differentiation of the Most Relevant Members of the B. pseudomallei Complex: B. mallei, B. pseudomallei, and B. thailandensis.

Authors:  Chinn-Woan Lowe; Benjamin A Satterfield; Daniel B Nelson; Joseph D Thiriot; Michael J Heder; Jordon K March; David S Drake; Cynthia S Lew; Annette J Bunnell; Emily S Moore; Kim L O'Neill; Richard A Robison
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 6.  Melioidosis: Clinical impact and public health threat in the tropics.

Authors:  Ramar Perumal Samy; Bradley G Stiles; Gautam Sethi; Lina H K Lim
Journal:  PLoS Negl Trop Dis       Date:  2017-05-11

7.  Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.

Authors:  Heather P McLaughlin; David Sue
Journal:  BMC Microbiol       Date:  2018-12-18       Impact factor: 3.605
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.